Bravo‑Rendón V, Hernández‑Reyes P, Orihuela‑Sandoval C, Oseguera‑Moguel J, Vásquez‑Ortiz Z

Language: English
References: 16
Page: 31-34
PDF size: 181.17 Kb.

ABSTRACT

Introduction: Cirrhotic cardiomyopathy, which is defined as systolic and/or diastolic dysfunction of the left ventricle at rest or stress (in the absence of other cardiovascular conditions), worsens prognosis after transplant or other liver surgical procedures. The aim of this study was to characterize left atrial function by speckle tracking in cirrhotic patients. Methods: We consecutively included 99 patients with liver cirrhosis of different etiologies. An echocardiographic evaluation with measurement of left ventricular and atrial function was performed using traditional techniques, three-dimensional measurements and speckle tracking. Results: The median age was 50.9 years and 40% were men. None had left ventricular systolic dysfunction. Diastolic dysfunction and left atrium enlargement were found in 27%, the latter with a significant increase according to Child Pugh stage. Left atrium pump function showed alterations in 29% of subjects. Conclusion: We found left ventricular diastolic dysfunction and alterations in left atrial systolic function measured by speckle tracking in cirrhotic patients.

REFERENCES

1. Kim MY, Baik SK, Won CS et al. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis. Korean J Hepatol. 2010; 16 (4): 376-382.

2. Merli M, Calicchia A, Ruffa A et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013; 24 (2): 172-176.

3. Wiese S, Hove JD, Muller S. Cardiac imaging in patients with chronic liver disease. Clin Physiol Funct Imaging. 2015: 1-10.

4. Licata A, Novo G, Colomba D et al. Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown). 2016; 17 (1): 26-36.

5. Fede G, Privitera G, Tomaselli T et al. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol Ann Gastroenterol. 2015; 28 (281): 31-40.

6. Milani A, Zaccaria R, Bombardieri G et al. Cirrhotic cardiomyopathy. Dig Liver Dis. 2007; 39 (6): 507-515.

7. Ruiz-Del-Arbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015; 21 (41): 11502-11521.

8. Zardi EM, Zardi DM, Chin D et al. Cirrhotic cardiomyopathy in the pre and post-liver transplantation phase. J Cardiol. 2016; 67 (2): 125-130.

9. Gassanov N, Caglayan E, Semmo N et al. Cirrhotic cardiomyopathy: a cardiologist’s perspective. World J Gastroenterol. 2014; 20 (42): 15492-15498.

10. Rahman S, Mallett SV, Mallett RS. Cirrhotic cardiomyopathy: implications for the perioperative management of liver transplant patients. World J Hepatol. 2015; 7 (3): 507-520.

11. Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014; 8 (3): 308-315.

12. Licata A, Mazzola A, Ingrassia D et al. Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med. 2014; 25 (9): 795-802.

13. Pudil R, Pelouch R, Praus R et al. Heart failure in patients with liver cirrhosis. Cor Vasa. 2013; 55 (4): 391-396.

14. Kazankov K, Holland-Fischer P, Andersen NH et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011; 31 (4): 534-540.

15. Ripoll C, Yotti R, Bermejo J et al. The heart in liver transplantation. J Hepatol. 2011; 54 (4): 810-822.

16. Sampaio F, Pimenta J, Bettencourt N et al. Left atrial function is impaired in cirrhosis: a speckle tracking echocardiographic study. Hepatol Int. 2014; 8 (1): 146-153.